Amazon Adds Novo Nordisk’s Wegovy Pill to Pharmacy Platform
This article first appeared on GuruFocus. Amazon Pharmacy (AMZN, Financials) stated that it is now selling Novo Nordisk’s…
New Wegovy pill offers weight loss alternative to injections
WILMINGTON, N.C. (WECT) – A new weight loss option is now available for people seeking alternatives to weekly…
Companies can make generic Ozempic as of next week, but don’t expect to get it soon
TORONTO — Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug…
Where Will Pfizer Be in 5 Years?
Pfizer’s stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…
GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds
This article first appeared on GuruFocus. Weight loss may be just one side effect of GLP-1 drugs. A…
1 Healthcare Giant Set to Soar in 2026
Novo Nordisk cut its guidance and changed its CEO this past year. Amid the troubling developments, the stock…
Popular weightloss drug Ozempic launched in India at the price of Rs…, check dosage, more details
Danish drugmaker Novo Nordisk launched its most popular weight-loss drug Ozempic in India on Friday. The price of…
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments
How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
By Deena Beasley Dec 12 (Reuters) – Alzheimer’s trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – National
Negotiations that could have led to coverage of weight-loss drug Wegovy under Canadian public health plans are not…